PT  - JOURNAL ARTICLE
AU  - Liao, Lei
AU  - Xiao, Wang
AU  - Zhao, Mervin
AU  - Yu, Xuanze
AU  - Wang, Haotian
AU  - Wang, Qiqi
AU  - Chu, Steven
AU  - Cui, Yi
TI  - Can N95 respirators be reused after disinfection? And for how many times?
AID  - 10.1101/2020.04.01.20050443
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.01.20050443
4099  - http://medrxiv.org/content/early/2020/04/17/2020.04.01.20050443.short
4100  - http://medrxiv.org/content/early/2020/04/17/2020.04.01.20050443.full
AB  - The Coronavirus Disease 2019 (COVID-19) pandemic has led to a major shortage of N95 respirators, which are essential to protecting healthcare professionals and the general public who may come into contact with the virus. Thus, it is essential to determine how we can reuse respirators and other personal protection in these urgent times. We investigated multiple commonly used and easily deployable, scalable disinfection schemes on media with particle filtration efficiency of 95%. Among these, heating (≤85 °C) under various humidities (≤100% RH) was the most promising, nondestructive method for the preservation of filtration properties in meltblown fabrics as well as N95-grade respirators. Heating can be applied up to 50 cycles (85 °C, 30% RH) without observation in the degradation of meltblown filtration performance. Ultraviolet (UV) irradiation was a secondary choice which was able to withstand 10 cycles of treatment and showed small degradation by 20 cycles. However, UV can also potentially impact the material strength and fit of respirators. Finally, treatments involving liquids and vapors require caution, as steam, alcohol, and household bleach may all lead to degradation of the filtration efficiency, leaving the user vulnerable to the viral aerosols.Competing Interest StatementProfessors Chu and Cui are founders of the company 4C Air, Inc. All other authors are directly employed by the company 4C Air, Inc.Funding StatementProfessors Chu and Cui are founders of the company 4C Air, Inc. All other authors are directly employed by the company 4C Air, Inc.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data is included in the manuscript text and/or included supplementary materials